Reviews medical records of people with advanced cervical cancer in Italy
Reviews past medical records of adults with cervical cancer treated in Italy.
Plain-language title generated from the registry record
Registry title: Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
Key facts
- Where
- Aviano, Bologna, Catania, Genova, Mestre, Milan, Modena, Naples, and Roma, ItalySee the 11 sites
Where in Italy
- Irccs Centro Di Riferimento Oncologico (CRO)Aviano, ItalyTaking people
- Oncologia Medica Policlinico Sant'Orsola - MalpighiBologna, ItalyTaking people
- Ginecologia ed Ostetricia A.O. CannizzaroCatania, ItalyTaking people
- Oncologia Medica 1 IRCCS Ospedale Policlinico San MartinoGenova, ItalyTaking people
- UOC Oncologia Medica Ospedale Dell'Angelo - Mestre Azienda USL3 SerenissimaMestre, ItalyNot yet recruiting
- Unità di Ginecologia Oncologica Medica IRCCS Ospedale San RaffaeleMilan, ItalyTaking people
- Unità Ostetricia, Ginecologia e Ginecologia Oncologica medica Humanitas San Pio XMilan, ItalyTaking people
- Oncologia A.O.U. di Modena - PoliclinicoModena, ItalyTaking people
- U.O.S. Trattamenti Innovativi dell'utero Istituto Nazionale Tumori IRCCS "Fondazione G. PascaleNaples, ItalyTaking people
- UOC Oncologia Medica ed Ematologia Azienda Ospedaliera Universitaria Luigi VanvitelliNaples, ItalyTaking people
- U.O.C. Ginecologia Oncologica Policlinico Agostino GemelliRoma, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- MSD Italia S.r.l.
- Trial code
- NCT06771193
- Record updated
- 20 July 2025
- Original description
Multicenter, Observational, Retrospective charts review. Observational study with descriptive purpose only. Retrospective data capture in consecutive patients diagnosed with CC who attended the Oncologic Clinics from Jan 2018 to Dec 2021 (using medical records, either electronic or not), inserted in eCRF and analyzed.Read full original descriptionShow less
RETRACE Study - Retrospective Observational Study Evaluating Disease Characteristics and Treatment Landscape of High-risk Locally Advanced (LA) or Recurrent / Metastatic (R/M) Cervical Cancer in Italy
Multicenter, Observational, Retrospective charts review. Observational study with descriptive purpose only. Retrospective data capture in consecutive patients diagnosed with CC who attended the Oncologic Clinics from Jan 2018 to Dec 2021 (using medical records, either electronic or not), inserted in eCRF and analyzed.
Inclusion: Patient (or their legally acceptable representatives) must have signed and dated the Informed Consent \& Privacy Form (ICF); Age ≥18 years; Diagnosis of a cervical cancer; Locally advanced stage (not suitable for curative surgery) or recurrent or metastatic disease; Any treatment received between January 2018 and December 2021 for advanced disease.
Exclusion: Patients who were administered with Pembrolizumab, Olaparib or Levantinib or medications from these class of drugs; Patients participating in a pharmacological clinical trial for the treatment of advanced disease; Patients who participated in a clinical trial.